Hepatocyte growth factor/cMET pathway activation enhances cancer hallmarks in adrenocortical carcinoma

Adrenocortical carcinoma (ACC) is a rare malignancy with poor prognosis and limited response to chemotherapy. Hepatocyte growth factor (HGF) and its receptor cMET augment cancer growth and resistance to chemotherapy, but their role in ACC has not been examined. In this study, we investigated the ass...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cancer Res
Prif Awduron: Phan, Liem M., Fuentes-Mattei, Enrique, Wu, Weixin, Velazquez-Torres, Guermarie, Sircar, Kanishka, Wood, Christopher G., Hai, Tao, Jimenez, Camilo, Cote, Gilbert J., Ozsari, Levent, Hofmann, Marie-Claude, Zheng, Siyuan, Verhaak, Roeland, Pagliaro, Lance, Cortez, Maria Angelica, Lee, Mong-Hong, Yeung, Sai-Ching J., Habra, Mouhammed Amir
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2015
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4592476/
https://ncbi.nlm.nih.gov/pubmed/26282167
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-14-3707
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg